CompanyTrack
B

BIOSCRIPT GROUP LIMITED

Active Macclesfield

Activities of other holding companies n.e.c.

0 employees Website
Life sciences and medical technology Activities of other holding companies n.e.c.
B

BIOSCRIPT GROUP LIMITED

Activities of other holding companies n.e.c.

Founded 14 Apr 2015 Active Macclesfield, England 0 employees bioscriptgroup.com
Life sciences and medical technology Activities of other holding companies n.e.c.
Accounts Submitted 27 Jun 2025
Confirmation Statement Submitted 6 Feb 2025
Net assets £81.19K £10.00 2024 year on year
Total assets £0.00 £110.61K 2024 year on year
Total Liabilities £29.51K £100.00 2024 year on year
Charges 2
2 outstanding

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Office (Macclesfield)

Nether Alderley, Macclesfield SK10 4EL

Office (UK)

The Ropewalks Newton Street Macclesfield Cheshire SK11 6QJ

Office (USA)

103 Carnegie Center Suite 300 Princeton, NJ 08540 6235

Credit Report

Discover BIOSCRIPT GROUP LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£106.00

Increased by £90.00 (+563%)

Net Assets

£81.19k

Decreased by £10.00 (-0%)

Total Liabilities

£29.51k

Increased by £100.00 (+0%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 27 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 2,405 Shares £18.91m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Mar 20212,010£18.91m£9k
14 Dec 2015395£395£1

Officers

Officers

2 active 5 resigned
Status
Gabrielle Alison SilverDirectorBritishEngland5215 Feb 2024Active
James MaxwellDirectorBritishUnited Kingdom4115 Feb 2024Active

Shareholders

Shareholders (1)

Bioscript Limited
100.0%
51,5106 Feb 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Bioscript Limited

United Kingdom

Active
Notified 2 Mar 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Andrew John Medley

Ceased 2 Mar 2021

Ceased

Group Structure

Group Structure

BIOSCRIPT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BIOSCRIPT MIDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BIOSCRIPT MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BIOSCRIPT HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BB SHELF 4 LLP united kingdom voting rights 75 to 100 percent limited liability partnership
BIOSCRIPT GROUP LIMITED Current Company
BIOSCRIPT STIRLING LIMITED united kingdom voting rights 75 to 100 percent
MEDOLOGIE LIMITED united kingdom voting rights 75 to 100 percent

Charges

Charges

2 outstanding

Documents

Company Filings

DateCategoryDescriptionDocument
27 Jun 2025AccountsAnnual accounts made up to 2024-09-30View(23 pages)
7 Feb 2025OfficersChange to director Mr James Maxwell on 2025-02-06View(2 pages)
6 Feb 2025Confirmation StatementConfirmation statement made on 2025-01-23 with updatesView(5 pages)
1 Oct 2024OfficersChange to director Mr James Maxwell on 2024-09-24View(2 pages)
1 Oct 2024Persons With Significant ControlChange to Bioscript Limited as a person with significant control on 2024-09-24View(2 pages)
27 Jun 2025 Accounts

Annual accounts made up to 2024-09-30

7 Feb 2025 Officers

Change to director Mr James Maxwell on 2025-02-06

6 Feb 2025 Confirmation Statement

Confirmation statement made on 2025-01-23 with updates

1 Oct 2024 Officers

Change to director Mr James Maxwell on 2024-09-24

1 Oct 2024 Persons With Significant Control

Change to Bioscript Limited as a person with significant control on 2024-09-24

Recent Activity

Latest Activity

Annual accounts made up to 2024-09-30

7 months ago on 27 Jun 2025

Change to director Mr James Maxwell on 2025-02-06

1 years ago on 7 Feb 2025

Confirmation statement made on 2025-01-23 with updates

1 years ago on 6 Feb 2025

Change to director Mr James Maxwell on 2024-09-24

1 years ago on 1 Oct 2024

Change to Bioscript Limited as a person with significant control on 2024-09-24

1 years ago on 1 Oct 2024